Omnes Capital's investments: Newronika

Sector 
Medical devices
Entry Date 
09/2019
Business 
Venture Capital

www.newronika.com

Newronika is the first company to develop a closed-loop system for the treatment of Parkinson’s disease

Newronika is the spin-off company of two of the world-leading research institutions in the field of Neurology, the Fondazione IRCCS Ca’Granda Ospedale Maggiore Policlinico Hospital and the University of Milan. Newronika restores brain and body functions with its innovative technology, translating their deep knowledge on bio-signal decoding into clinical practice with the aim of developing new treatments and improve existing ones. Newronika comprises a multidisciplinary team involving neurophysiology, neurology, biomedical engineering, neuropsychology, bioinformatics, and biotechnologies.

Latest news